Surrey develops hepatitis C model that could help improve treatment

May 29, 2018

The University of Surrey has created a new mathematical model that details how the Hepatitis C (HCV) infection develops and behaves more accurately than previous models. This new model has the potential to improve treatment for the infection that affects 215,000 people in the United Kingdom.

HCV is a virus that infects the liver and, if left untreated, can potentially be life-threatening. The virus is usually spread through blood to blood contact and often doesn't have any noticeable symptoms until the liver is significantly damaged. When symptoms surface - such as tiredness, loss of appetite and vomiting - they are regularly mistaken for other conditions.

In a new paper published by the journal Viruses, Professor of Mathematics Philip Aston proposes a new mathematical model that may give clinicians and drug manufacturers a better understanding of the effect of drug treatment on the virus. The model was developed by taking account of recent biological insights into the dynamics of the infection and incorporating these into the model.

The new model has given rise to three recommendations for changes in the treatment of HCV: According to the World Health Organisation, there are an estimated 71 million people in the world that have chronic HCV infection which, if left untreated, may result in cirrhosis of the liver or liver cancer. Around 1.8 million new HCV infections occur each year and almost 400,000 people die each year from the infection.

Philip Aston, Professor of Mathematics at the University of Surrey and author of the paper, said: "We have developed a mathematical model that is better able to predict the dynamics of hepatitis C infection during treatment. We believe that this new model provides an opportunity to improve the treatment for patients who are suffering from this illness."
-end-
Note to editors

The paper: A New Model for the Dynamics of Hepatitis C Infection: Derivations, Analysis and Implications; Viruses 10(4), 195, April 2018.

Professor Philip Aston is available for interview.

University of Surrey

Related Hepatitis Articles from Brightsurf:

Busting Up the Infection Cycle of Hepatitis B
Researchers at the University of Delaware have gained new understanding of the virus that causes hepatitis B and the ''spiky ball'' that encloses its genetic blueprint.

Liver cancer: Awareness of hepatitis D must be raised
Scientists from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) have studied the most serious consequence of chronic hepatitis: hepatocellular carcinoma.

Hepatitis B: New therapeutic approach may help to cure chronic hepatitis B infection
Researchers at Helmholtz Zentrum München, Technical University of Munich (TUM) and the German Center for Infection Research (DZIF) have developed a novel therapeutic approach to cure chronic hepatitis B.

Anti-hepatitis medicine surprises
A new effective treatment of hepatitis C not only combats the virus, but is also effective against potentially fatal complications such as reduced liver functioning and cirrhosis.

Nanotechnology delivers hepatitis B vaccine
X-ray imaging shows that nanostructured silica acts as a protective vehicle to deliver intact antigen to the intestine so that it can trigger an immune response.

Checkmate for hepatitis B viruses in the liver
Researchers at Helmholtz Zentrum München and the Technical University of Munich, working in collaboration with researchers at the University Medical Center Hamburg-Eppendorf and the University Hospital Heidelberg, have for the first time succeeded in conquering a chronic infection with the hepatitis B virus in a mouse model.

How common is Hepatitis C infection in each US state?
Hepatitis C virus infection is a major cause of illness and death in the United States and injection drug use is likely fueling many new cases.

New strains of hepatitis C found in Africa
The largest population study of hepatitis C in Africa has found three new strains of the virus circulating in the general population in sub-Saharan Africa.

High stability of the hepatitis B virus
At room temperature, hepatitis B viruses (HBV) remain contagious for several weeks and they are even able to withstand temperatures of four degrees centigrade over the span of nine months.

Findings could lead to treatment of hepatitis B
Researchers have gained new insights into the virus that causes hepatitis B -- a life-threatening and incurable infection that afflicts more than 250 million people worldwide.

Read More: Hepatitis News and Hepatitis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.